A new White Paper titled “Pharmacy Benefit Alternative Funding Programs: Key Considerations for Self-Funded Plan Sponsors” details how the saving…
On July 9, 2024, the Federal Trade Commission (FTC) released an interim report highlighting the significant impact of pharmacy benefit…
On July 2, 2024, Aimed Alliance submitted a comment to the Centers for Medicare & Medicaid Services (CMS) regarding the…
On June 26, 2024, the Oregon Prescription Drug Affordability Board (PDAB) voted to pause all ongoing drug reviews for the…
A new analysis found that the Inflation Reduction Act (IRA) could raise out-of-pocket costs for 3.5 million Medicare Part D…
On June 14, the Colorado Prescription Drug Affordability Board (PDAB) voted that a prescription drug used to treat various forms…
On May 31, 2024, Aimed Alliance released a new fact sheet on prescription drug affordability boards (PDABs). The new resource…
On May 20, 2024, Governor Phil Scott signed H.766, which aims to reform prior authorization practices and reduce administrative delays…
On May 20, 2024, Maryland’s Prescription Drug Affordability Board (PDAB) voted to initiate cost review and affordability studies for six…
On May 7, 2024, Aimed Alliance submitted a letter to the Nebraska Banking, Commerce, and Insurance Committee regarding L.B.33, which…